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Abstract
Background: Genetic variants in the complement component 3 gene (C3) have been shown to be associated with age-
related macular degeneration (AMD) in Caucasian populations of European descent. In particular, a nonsynonymous coding
variant, rs2230199 (R102G), is presumed to be the most likely causal variant in the C3 locus based on strong statistical
evidence for disease association and mechanistic functional evidence. However, the risk allele is absent or rare (,1%) in
Japanese and Chinese populations, and the association of R102G with AMD has not been reported in Asian populations.
Genetic heterogeneity of disease-associated variants among different ethnicities is common in complex diseases. Here, we
sought to examine whether other common variants in C3 are associated with wet AMD, a common advanced-stage
manifestation of AMD, in a Japanese population.
Methodology/Principal Findings: We genotyped 13 tag single nucleotide polymorphisms (SNPs) that capture the majority
of common variations in the C3 locus and tested for associations between these SNPs and wet AMD in a Japanese
population comprising 420 case subjects and 197 controls. A noncoding variant in C3 (rs2241394) exhibited statistically
significant evidence of association (allelic P= 8.3261024; odds ratio = 0.48 [95% CI = 0.31–0.74] for the rs2241394 C allele).
Multilocus logistic regression analysis confirmed that the effect of rs2241394 was independent of the previously described
loci at ARMS2 and CFH, and that the model including variants in ARMS2 and CFH plus C3 rs2241394 provided a better fit than
the model without rs2241394. We found no evidence of epistasis between variants in C3 and CFH, despite the fact that they
are involved in the same biological pathway.
Conclusions: Our study provides evidence that C3 is a common AMD-associated locus that transcends racial boundaries and
provides an impetus for more detailed genetic characterization of the C3 locus in Asian populations.
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Introduction
Age-related macular degeneration (AMD) is a common
multifactorial and heterogeneous disorder, characterized by
progressive degeneration of the central region of the retina
(macula) [1,2]. Pigmentary abnormalities of the retinal pigment
epithelium (RPE) and extracellular deposits (drusen) under the
retina are among the early-stage manifestations of AMD. As the
condition progresses, extensive atrophy of the RPE and outer
retina (geographic atrophy or dry AMD) or abnormal vessel
growth underneath the macula (exudative or wet AMD) are
common advanced-stage manifestations. AMD affects 30–50
million individuals worldwide and is a leading cause of legal
blindness among older individuals in developed countries [1,2].
Although the precise etiology of AMD remains elusive, genetic
studies have provided significant insights into the molecular basis
of AMD. Several genes encoding proteins involved in the
complement pathway have been shown to be associated with
susceptibility to AMD, including the complement factor H gene
(CFH) on chromosome 1q32 [3–5], two neighboring genes,
complement component 2 (C2) and complement factor B (CFB)
on 6p21 [6–8], the complement factor I gene (CFI) on 4q25 [9,10],
and the complement component 3 gene (C3) on 19p13 [11–13].
These findings strongly implicate aberrant regulation and/or
activation of the complement pathway in the mechanism of
susceptibility to AMD. In addition to the association with
complement pathway genes, AMD has been convincingly shown
to be associated with two adjacent genes on 10q26 (age-related
maculopathy susceptibility 2 [ARMS2] and high-temperature
requirement factor H [HTRA1]) [14–16], which together account
for nearly half of the heritability of AMD [7].
AMD susceptibility loci have been primarily discovered in
populations of European descent, of which only the association of
CFH [17–20] and the ARMS2/HTRA1 loci [14,21,22] have been
convincingly validated in Asian populations. We recently reported
a significant association of wet AMD in a Japanese population with
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the same susceptibility variant near CFI as that observed in
individuals of European descent [23], indicating that, along with
CFH and ARMS2/HTRA1, CFI is a susceptibility locus of AMD
that transcends racial boundaries. However, studies have also
revealed the existence of genetic heterogeneity in AMD suscep-
tibility at the C3 locus between populations of European and Asian
descent. A nonsynonymous coding variant in C3, rs2230199
(R102G), was consistently found to be associated with AMD in
Caucasian populations [11–13,24,25], but not in Asians [25–28].
Furthermore, the allelic frequency of the R102G variant is absent
in Japanese and rare (,1%) in Chinese populations, according to
the data from the International HapMap Project and published
studies [25,27,28,29], while risk allele frequency is almost 20% in
individuals of European descent [25]. It has been proposed that
genetic effects of disease-associated variants are similar across
racial boundaries regardless of their widely divergent allelic
frequency between different populations [30]. However, it has
also been documented that genetic heterogeneity of disease
susceptibility between ethnic groups is common in complex
diseases [31,32], and thus, disease-associated variants present in
populations of European descent might not be applicable to Asian
populations because of underlying genetic heterogeneity. Indeed,
two recent studies have suggested a role for common intronic
variants of the C3 locus in susceptibility to wet AMD in Japanese
and Chinese populations [26,27], implying that more common C3
variants are associated with the disease in Asians. Here we
genotyped 13 tag single nucleotide polymorphisms (SNPs) that
capture the majority of common variations in the C3 locus and
tested for associations between these SNPs and wet AMD in a
Japanese population comprising 420 case subjects and 197
controls.
Materials and Methods
Ethics Statement
The study protocol was approved by the Institutional Review
Board at Kobe University Graduate School of Medicine and
performed in accordance with the Declaration of Helsinki. Written
informed consent was obtained from all subjects before participa-
tion in this study.
Study participants
All cases and controls included in this study were Japanese
individuals recruited from the Department of Ophthalmology at
Kobe University Hospital in Kobe, Japan. The demographic
details of the study population are shown in Table 1. All cases and
control subjects underwent comprehensive ophthalmic examina-
tion, including visual acuity measurement, slit-lamp examination,
and dilated funduscopic examination. Fundus findings in each eye
were classified according to the clinical age-related maculopathy
staging system (CARMS) [33] as previously described [7,12]. All of
our case subjects had wet AMD and associated manifestations
such as nondrusenoid pigment epithelial detachment, serous or
hemorrhagic retinal detachment, and subretinal or sub-RPE
hemorrhages and fibrosis; they were categorized as having
CARMS stage 5 [33]. The controls were individuals aged 56
years or older and were defined as cases without macular
degeneration and changes, such as drusen or pigment abnormal-
ities. Thus, controls were categorized as having CARMS stage 1
[33] on the basis of comprehensive ophthalmic examinations.
Genotyping
Genomic DNA was extracted from peripheral blood using
standard methodology. Genotyping was performed using the
TaqManH SNP Genotyping Assays (Applied Biosystems, Foster City,
CA) on a StepOnePlusTM Real-Time PCR System (Applied
Biosystems) in accordancewith themanufacturer’s recommendations.
SNP selection
To comprehensively yet efficiently screen C3 sequences for
common genetic variations, tag SNPs were selected from the
HapMap Project database for the Japanese in Tokyo (JPT)
population using the tag selection tool. Thirteen tag SNPs were
selected for genotyping, which captured 29 of 34 SNPs in the C3
locus exhibiting a minor frequency greater than 10% with a mean
r2 value of 0.986.
Statistical analysis
Allelic associations were evaluated for each SNP by chi-square tests
on 262 contingency tables using the software package PLINK v1.00
(http://pngu.mgh.harvard.edu/purcell/plink/) [34]. The odds ratio
(OR) and corresponding 95% confidence interval (CI) were calculated
relative to the major allele. In addition to obtaining nominal P values,
corrected empirical P values for multiple testing were generated by
10,000 permutation tests using the Max (T) permutation procedure
implemented in PLINK [34]. We also applied a Bonferroni
correction, where nominal P-values were multiplied by 13 (the
number of SNPs tested for association). To adjust for age and gender
differences between the case and control subjects, logistic regression
analysis was performed using SNPStats (http://bioinfo.iconcologia.
net/SNPStats), with age and gender controlled as covariates. Age and
gender were included in this model as a continuous covariate
measured in years and a categorical covariate, respectively. Deviations
from theHardy–Weinberg equilibriumwere tested using the exact test
implemented in PLINK [35]. Haploview software was used to assess
linkage disequilibrium (LD) patterns and haplotype association
statistics [36]. Haplotype blocks were determined using the solid
spine of LD algorithm with a minimum D’ of 0.8. To correct for
multiple testing in the haplotype association analysis, 10,000
permutations were run using this software. An omnibus (or global)
test of the haplotype association was performed with PLINK. To
determine whether a single variant could explain an entire omnibus
haplotype association, conditional haplotype-based likelihood ratio
tests implemented in PLINK were conducted. The haplotype
association was assessed further using sliding window analyses of four
adjacent SNPs across the C3 region. For this analysis, sliding windows
of overlapping haplotypes were tested in sequence. For example, SNPs
rs2250656, rs2230205, rs11569429, and rs11672613 were treated
as a single haplotype, followed by SNPs rs2230205, rs11569429,
rs11672613, and rs428453. The significance values were evaluated
on the basis of omnibus test P values. The sliding window anal-
yses were conducted using the PLINK software. The FASTSNP
program (http://fastsnp.ibms.sinica.edu.tw/pages/input_Candidate-
GeneSearch.jsp) was used to predict the function of a SNP of
interest [37].
Table 1. Characteristics of the study population.
Wet AMD Controls
Number of subjects 420 197
Gender (male/female) 331/89 117/80
Mean age 6 SD (years) 7467.5 7266.0
Age range (years) 54–94 56–95
AMD: age-related macular degeneration; SD: standard deviation.
doi:10.1371/journal.pone.0028847.t001
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Table 2. Results of single-marker association test.
Minor allele frequency Association Results
SNP (location)
Position in NCBI
build 36.3 Minor allele Cases Controls Allelic P-value Allelic OR (95% CI)
Corrected
empirical P-value*
rs2250656 (intron 2) 6658534 bp C 0.230 0.241 0.660 0.94 (0.71–1.24) 1
rs2230205 (exon 14; T612T) 6649704 bp T 0.413 0.406 0.816 1.03 (0.81–1.31) 1
rs11569429 (intron 14) 6649074 bp T 0.132 0.150 0.403 0.86 (0.61–1.22) 0.995
rs11672613 (intron 17) 6645246 bp C 0.470 0.452 0.544 1.08 (0.85–1.37) 1
rs428453 (exon 19; V807V) 6642157 bp C 0.096 0.140 0.0240 0.66 (0.46–0.95) 0.225
rs432001 (intron 24) 6633683 bp G 0.152 0.155 0.912 0.98 (0.70–1.37) 1
rs7257062 (intron 29) 6625945 bp C 0.241 0.211 0.247 1.19 (0.89–1.58) 0.929
rs2241393 (intron 29) 6625304 bp G 0.329 0.305 0.40 1.12 (0.86–1.45) 0.995
rs2241394 (intron 29) 6625230 bp C 0.052 0.104 8.3261024 0.48 (0.31–0.74) 0.0102
rs1389623 (intron 33) 6624197 bp A 0.082 0.102 0.263 0.79 (0.53–1.19) 0.942
rs7951 (exon 35; A1437A) 6621991 bp A 0.082 0.102 0.263 0.79 (0.53–1.19) 0.942
rs344555 (intron 37) 6619360 bp T 0.385 0.343 0.156 1.20 (0.93–1.54) 0.802
rs11569562 (intron 38) 6618753 bp G 0.477 0.515 0.215 0.86 (0.68–1.09) 0.897
OR: odds ratio; CI: confidence intervals.
*Empirical P-values corrected for multiple testing (corrected empirical P-values) were generated by 10,000 permutation tests using Max (T) permutation procedure
implemented in the PLINK software.
doi:10.1371/journal.pone.0028847.t002
Figure 1. Linkage disequilibrium (LD) structure of the C3 locus. LD was measured using data from all subjects in the present study. The
haplotype blocks were determined by the solid spine of LD method implemented in the Haploview software. Each box provides estimated statistics
of the coefficient of determination (r2), with darker shades representing stronger LD.
doi:10.1371/journal.pone.0028847.g001
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To examine a genetic effect detected here in the context of three
validated AMD-risk loci for Asians (the A69S variant
[rs10490924] in ARMS2 [14,21,22] and the I62V variant
[rs800292] and Y402H variant [rs1061170] in CFH [17–20]),
we conducted logistic regression analyses with the R statistical
analysis package (http://www.r-project.org/). For each locus, the
genetic model of best fit was determined before genotypes were
coded according to additive, dominant, and recessive models.
Akaike Information Criterion (AIC) was used to select the model of
best fit. The best models for each locus were then combined into
multilocus models, and an effect of the C3 variant after controlling
for ARMS2 A69S, CFH I62V, and CFH Y402H was estimated.
Furthermore, we compared two logistic regression models (the full
model including all four variants versus a reduced model in which
the C3 variant was omitted) by using a likelihood ratio test and
calculating AIC values. To determine epistatic effects between C3
rs2241394 and CFH I62V or Y402H, pairwise interaction analysis
was performed using the epistasis option in PLINK.
Results
None of the 13 SNPs reported in the present study showed
significant deviation from the Hardy–Weinberg equilibrium in
both the case and control subjects (P.0.05). Marker information,
allelic frequencies, and summary statistics for all evaluated SNPs
are shown in Table 2. In single-SNP analyses, two of the 13
SNPs showed nominally significant associations with wet
AMD (rs2241394, nominal P=8.3261024; rs428453, nominal
P=0.0240), of which only rs2241394 withstood multiple test
corrections (corrected empirical P=0.0102; Bonferroni-corrected
P=0.0108, Table 2). The minor allele C of rs2241394 was
associated with protection against the disease, with a frequency of
0.052 in disease cases and 0.104 in controls (per allele OR=0.48
[95% CI= 0.31–0.74]; Table 2). In a dominant genetic model,
OR for individuals carrying at least one copy of the protective
allele was 0.45 (95% CI=0.28–0.72; P=7.8161024). Inclusion of
age and gender as covariates in the logistic regression model did
not substantially change the significance of the association
(age- and gender-adjusted OR=0.48 [95% CI= 0.30–0.75],
P=0.0016, additive model; age- and gender-adjusted OR=0.44
[95% CI=0.27–0.72], P=0.0012, dominant model).
The pairwise LD structure was constructed with the 13 SNPs
genotyped (Figure 1). Five haplotype blocks were defined, and
association with the disease was restricted to block 4 where the
disease-associated SNP rs2241394 resided as demonstrated by the
significant omnibus result (omnibus P=0.00367 at 2 degrees of
freedom, Table 3). Only one haplotype in block 4 was found to be
significantly associated with the disease, with a haplotype
frequency of 0.052 in affected individuals and 0.104 in controls
(P=8.061024; OR=0.48 [95% CI= 0.31–0.74]; Table 3). This
association remained statistically significant after correction for
multiple testing (permutation P=0.011). The disease-associated
Table 3. Association of C3 haplotype blocks with wet AMD.
Frequency
Haplotype Cases Controls P-value* OR (95% CI) Omnibus P-value{
Block 1
rs2250656|rs2230205|rs11569429
TTC 0.401 0.399 0.952 1.01 (0.79–1.29) 0.857
TCC 0.362 0.351 0.699 1.05 (0.82–1.35)
CCT 0.125 0.141 0.442 0.86 (0.61–1.22)
CCC 0.092 0.093 0.967 0.99 (0.65–1.49)
CTC 0.012 0.0007 0.399 1.57 (0.43–5.74)
Block 2
rs11672613|rs428453
CG 0.468 0.442 0.388 1.11 (0.87–1.41) 0.153
TG 0.435 0.419 0.576 1.07 (0.84–1.37)
TC 0.094 0.130 0.0595 0.70 (0.48–1.02)
Block 3
rs432001|rs7257062
AT 0.619 0.643 0.420 0.91 (0.71–1.16) 0.691
AC 0.229 0.202 0.299 1.16 (0.87–1.56)
GT 0.140 0.146 0.779 0.95 (0.67–1.33)
GC 0.012 0.008 0.574 1.57 (0.43–5.74)
Block 4
rs2241393|rs2241394
CG 0.619 0.591 0.353 1.12 (0.88–1.43) 0.00367
GG 0.329 0.305 0.40 1.12 (0.86–1.45)
CC 0.052 0.104 8.061024 0.48 (0.31–0.74)
Block 5
rs1389623|rs7951|rs344555
GGC 0.521 0.556 0.260 0.87 (0.68–1.11) 0.0846
GGT 0.385 0.343 0.156 1.20 (0.93–1.54)
AAC 0.070 0.101 0.0596 0.67 (0.44–1.02)
OR: odds ratio; CI: confidence intervals.
The association of haplotype CC in block 4 remained statistically significant after correction for multiple testing (permutation P=0.011).
*The P-values were calculated by the chi-square test on haplotype counts (1 degree of freedom).
{The omnibus P-values were calculated by the PLINK software (4 degrees of freedom for block 1; 2 degrees of freedom for block 2, 4, and 5; 3 degrees of freedom for
block 3).
doi:10.1371/journal.pone.0028847.t003
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haplotype was completely described by the protective allele C of
rs2241394, and a conditional haplotype-based likelihood ratio test
revealed that the significant omnibus haplotype association detected
in haplotype block 4 disappeared when it was estimated to be
conditional on rs2241394 (omnibus P=0.85), confirming that
rs2241394 is responsible for the haplotype association detected in
this LD block. To further assess haplotype associations, we
conducted a sliding window analysis of four adjacent SNPs across
the C3 region. Significant associations were observed only around
rs2241394 (Table 4), and the strongest association was found when
four variants—rs2241393, rs2241394, rs1389623, and rs7951—
were included together (omnibus P=9.8161024, Table 4).
To examine the possibility that the disease-associated SNP
rs2241394 might be correlated with untyped SNPs, we investigat-
ed the LD structure across the genomic region extending
approximately 200 kb upstream and downstream of the C3 locus.
Genotype data were retrieved from the 1000 Genome Project
(August 2010 release) [38] and International HapMap (release 24)
JPT+CHB datasets [39], and correlations (as defined by r2 values)
were examined. In this genomic region, we found 594 SNPs but
did not identify any SNPs that are highly correlated with
rs2241394 (all pairwise r2,0.45).
Next, we examined the genetic effect of rs2241394 in the
context of three validated AMD-risk loci for Asians (ARMS2 A69S
[14,21,22], CFH I62V [17–19], and CFH Y402H [20]). Using
unconditional logistic regression, the genetic model of best fit for
C3 rs2241394, ARMS2 A69S, CFH I62V, and CFH Y402H was
determined and genotypes were coded according to additive,
dominant, and recessive models. On the basis of AIC values,
ARMS2 A69S, and CFH I62V had the best fit under an additive
model, and C3 rs2241394 and CFH Y402H had the best fit under
a dominant model. The best models were then combined into
multilocus logistic regression models. After including the effects of
CFH I62V, CFH Y402H, and ARMS2 A69S, C3 rs2241394
retained significant association (model 1; Table 5). Furthermore,
we found that the model including all four variants–C3 rs2241394,
ARMS2 A69S, CFH I62V, and CFH Y402H–fit significantly better
than the model without C3 rs2241394 (likelihood ratio test
x2 = 10.32, P=0.00132, model 1 vs. model 2; AIC=692.0 and
700.3 for model 1 and 2, respectively; Table 5).
Finally, we conducted pairwise interaction analysis to evaluate
potential epistatic effects between C3 rs2241394 and CFH I62V or
CFH Y402H, because the proteins encoded by these loci
biologically interact in the complement pathway [40]. However,
we did not find any evidence of epistasis between rs2241394 and
CFH variants (all P.0.05).
Discussion
We genotyped 13 tag SNPs that capture the majority of
common genetic variations in the C3 locus and found statistically
significant evidence for association between an intronic C3
variant (rs2241394) and wet AMD in a Japanese population
(P=8.3261024). Haplotype analyses identified the LD block
where rs2241394 resides as being the only significant locus, and
haplotype association was completely explained by rs2241394.
Logistic regression analysis showed that the effect of rs2241394 is
independent of the established associations of ARMS2 A69S, CFH
I62V, and CFH Y402H, and that the model including these three
established loci plus C3 rs2241394 provides a better fit than the
model without rs2241394. Although the proteins encoded by C3
and CFH are involved in the same biological pathway, we found
no evidence of epistasis between rs2241394 and the two CFH
variants.
Complement has emerged as an important element in AMD
pathology [41,42], because of the identification of various
complement-related molecules in drusen and nearby RPE [42].
In addition, recent successes in the identification of genetic
susceptibility loci for AMD have revealed several molecules
involved in the complement pathway, including CFH [3–5],
CFB [6–8], C2 [6–8], CFI [9,10,23], and C3 [11–13].
Furthermore, systemic complement activation was observed in
AMD patients [43–45] and nutritional supplementation with zinc
was shown to delay the progression of AMD [46], an effect likely
mediated by an inhibitory effect of zinc on complement activity
[47]. C3 is a central component of all three pathways of
complement activation: the alternative, classical, and mannose-
binding lectin pathways, all of which lead to the cleavage of C3
into biologically active C3a and C3b fragments [40]. Notably, an
animal study has shown that C3 deficiency prevented the
formation of choroidal neovascularization induced by the rupture
of Bruch’s membrane with laser photocoagulation in eyes of
Table 4. Four-marker sliding window haplotype analysis over
the entire C3 locus.
Omnibus P Value*
SNP 4-Marker
rs2250656 0.959
rs2230205 0.706
rs11569429 0.476
rs11672613 0.503
rs428453 0.269
rs432001 0.0515
rs7257062 0.0555
rs2241393 9.8161024
rs2241394 0.00103
rs1389623 0.0738
rs7951 -
rs344555 -
rs11569562 -
SNP: single nucleotide polymorphism.
*Omnibus P value corresponding to the haplotype with the listed SNP as the
first SNP in the haplotype.
doi:10.1371/journal.pone.0028847.t004
Table 5. Multilocus logistic regression analysis of C3
rs2241394, ARMS2 A69S, CFH I62V, and CFH Y402H.
Model Effect P-value OR (95% CI) AIC
1 C3 rs2241394 0.00125 0.43 (0.26–0.72) 692.0
ARMS2 A69S 2.3061029 2.15 (1.67–2.77)
CFH I62V 3.2461025 1.76 (1.35–2.30)
CFH Y402H 0.00302 2.34 (1.33–4.10)
2 ARMS2 A69S 1.6661029 2.15 (1.68–2.77) 700.3
CFH I62V 1.8761025 1.78 (1.37–2.32)
CFH Y402H 0.00523 2.20 (1.26–3.82)
AIC: Akaike information criterion.
doi:10.1371/journal.pone.0028847.t005
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C32/2mice [48], indicating that C3 is a key factor in the
development of choroidal neovascularization.
A nonsynonymous coding C3 variant, rs2230199 (R102G), is
strongly associated with AMD in populations of European descent,
and this variant is presumed to be the most likely causal variant
responsible for the disease association based on mechanistic
functional evidence [11–13,49,50]. However, the association of
R102G has not been reported in Asian populations [25–28], and
allele frequencies of R102G vary widely among different
ethnicities. For example, the risk allele is absent in Japanese [29]
and rare (,1%) in Chinese populations [25,27,28], while the
corresponding rate in Caucasians is 20% [25]. In the present
study, we have found that a more common SNP of C3, rs2241394,
is associated with AMD in a Japanese population. This association
has not been documented by any previous genetic studies of AMD
in European populations. These findings suggest that the
susceptibility conferred by the R102G variant does not transcend
ethnic lines and that there may be a significant difference in
disease susceptibility loci in the C3 region of populations of
European and Asian descent. Notably, rs2241394 has previously
been reported in a Japanese population to be associated with
polypoidal choroidal vasculopathy [26], a major subphenotype of
wet AMD in East Asian populations [51–53], and the direction of
association was consistent with our findings. However, suggestive
evidence for association of rs2250656 with wet AMD previously
reported in a Chinese cohort [27] was not detected in the present
study. We sought further evidence from a recent genome-wide
association study of wet AMD in Japanese populations [29];
however, the arrays used in this study (Illumina HumanHap610-
Quad BeadChip and Illumina HumanHap550v3 Beadchip) did
not suit rs2241394.
The C3 variant rs2241394 is an intronic SNP, and there is
currently no evidence supporting its functional relevance. Using
the FASTSNP program [37], we investigated potential functions
of rs2241394. According to the analysis, this SNP was identified as
lying in an intronic enhancer region created by a ‘‘CRG’’ change
at rs2241394 that may lead to the creation of a binding site for the
transcriptional factor GATA-1. Therefore, this SNP may have a
functional relevance to disease risk for Japanese populations in the
absence of surrounding 1000 Genome Project and HapMap SNPs
that are highly correlated with rs2241394; however, fine-mapping
and resequencing efforts are required to identify any potential as
yet unidentified variants of more functional relevance.
In conclusion, we report a significant association between wet
AMD and a common noncoding C3 variant in a Japanese
population. Our study provides evidence that C3 is a common
AMD-associated locus that transcends racial boundaries and
provides an impetus for more detailed genetic characterization of
the C3 locus in Asian populations.
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